GOVX - GeoVax Labs Inc logo

GOVX

GeoVax Labs Inc

GeoVax Labs develops human vaccines and immunotherapies targeting infectious diseases like COVID-19, HIV, and Ebola, along with therapeutic vaccines for solid tumors. Its key projects include GEO-CM04S1 and Gedeptin, aimed at broad health challenges.

โš•๏ธ Healthcare NASDAQ Listed 1999 $ USD
$1,000 invested 5 years ago โ†’$0today

Score Overview

1 Year
Score
Net Growth4.84%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth-100.00%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score4.6
Net Growth-10.22%
Net Trend80%
Net Income Consistencyโ€”
Rev Growth-100.00%
Rev Trend20%
Revenue Consistencyโ€”
10 Years
Score
Net Growth-4x
Net Trend60%
Net Income Consistency
Rev Growth-100.00%
Rev Trend40%
Revenue Consistency
20 Years
Score2.2
Net Growth-32x
Net Trend60%
Net Income Consistency
Rev Growth-100.00%
Rev Trend40%
Revenue Consistency
All Time
Score
Net Growth-119.48%
Net Trend63%
Net Income Consistency
Rev Growth-100.00%
Rev Trend39%
Revenue Consistency

See the full market ranking โ†’

GeoVax Labs Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 1M to $ 2M and net income went from -$ 2M to -$ 21M. Revenue increased in 1 of those 5 years; net income in 4.

Across GeoVax Labs Inc's full reported history, from 1999 to 2025, revenue grew from $ 2M to $ 2M and net income went from -$ 9M to -$ 21M. Revenue increased in 39% of the years measured; net income in 63%.

GeoVax Labs Inc currently holds a 20-year HDB Score of 2.2 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 0.73โ€”
1 Year2025-08-12
$ 17.48-95.85%
5 Years2021-08-12
$ 1.53K-99.95%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 0.00-$ 20M$ 3M
2025$ 2M-$ 21M$ 3M
2024$ 3M-$ 24M$ 5M
2023$ 0.00-$ 25M$ 6M
2022$ 81K-$ 14M$ 27M
2021$ 385K-$ 18M$ 11M
2020$ 1M-$ 2M$ 9M
2019$ 1M-$ 2M$ 283.34K
2018$ 963K-$ 2M$ 260K
2017$ 1M-$ 2M$ 312.73K
2016$ 828.92K-$ 3M$ 454.03K
2015$ 428.08K-$ 2M$ 1M
2014$ 882.96K-$ 2M$ 1M
2013$ 2M-$ 2M$ 2M
2012$ 2M-$ 2M$ 1M
2011$ 4M-$ 2M$ 1M
2010$ 5M-$ 2M$ 1M
2009$ 3M-$ 3M$ 3M
2008$ 2M-$ 3M$ 2M
2007$ 237K-$ 4M$ 1M
2006$ 852.9K-$ 584.17K$ 2M
2005-$ 1M$ 78.38K
2004-$ 2M$ 7.83K
2003-$ 3M$ 326.00
2002$ 180.24K-$ 618.14K
2001$ 2M-$ 13M$ 725.36K
2000$ 859.84K-$ 8M$ 2M
IPO1999$ 2M-$ 9M$ 31.09K

Explore beyond GOVX

You're looking at GeoVax Labs Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies